Performance characteristics of an immunoturbidimetric assay for lipoprotein-associated phospholipase A2

Clinica Chimica Acta

Volumn 406, Issue 1-2, 2009, Pages 66-70

  Rawlins, Mindy L ^a   La'ulu, Sonia L ^a   Moon, Natalie ^b   Roberts, William L ^c  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b ARUP LABORATORIES   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Immunoassay; Imprecision; Linearity; Lipoprotein associated phospholipase A2; Method comparison

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BILIRUBIN; HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DILUTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZING; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THAWING; TURBIDIMETRY;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; AGED; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; INDICATORS AND REAGENTS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY;

EID: 67650251246     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.05.010     Document Type: Article

References (11)

1. Caslake M.J., and Packard C.J. Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke. Nat Clin Pract Cardiovasc Med 2 (2005) 529-535
2. McConnell J.P., and Hoefner D.M. Lipoprotein-associated phospholipase A2. Clin Lab Med 26 (2006) 679-697 vii.
3. Lavi S., Herrmann J., Lavi R., McConnell J.P., Lerman L.O., and Lerman A. Role of lipoprotein-associated phospholipase A2 in atherosclerosis. Curr Atheroscler Rep 10 (2008) 230-235
4. Virani S.S., and Nambi V. The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis. Curr Atheroscler Rep 9 (2007) 97-103
5. Hoogeveen R.C., and Ballantyne C.M. Plac test for identification of individuals at increased risk for coronary heart disease. Expert Rev Mol Diagn 5 (2005) 9-14
6. Davidson M.H., Corson M.A., Alberts M.J., et al. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol 101 (2008) 51F-57F
7. Caslake M.J., Packard C.J., Suckling K.E., Holmes S.D., Chamberlain P., and Macphee C.H. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis 150 (2000) 413-419
8. diaDexus Plac Turbidimetric Immunoassay Package Insert. updated 7/17/2008.
9. Owen W.E., and Roberts W.L. Performance characteristics of the IMMULITE 2000 androstenedione assay. Clin Chim Acta 383 (2007) 168-171
10. Lanman R.B., Wolfert R.L., Fleming J.K., et al. Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults. Prev Cardiol 9 (2006) 138-143
11. McConnell J.P., and Jaffe A.S. Variability of lipoprotein-associated phospholipase A2 measurements. Clin Chem 54 (2008) 932-933